NCM Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.49M Sell
2,914
-15
-0.5% -$15.3K 1.08% 17
2026
Q1
$2.69M Sell
2,929
-174
-6% -$176K 0.96% 20
2025
Q4
$3.34M Sell
3,103
-140
-4% -$134K 1.24% 17
2025
Q3
$2.47M Buy
3,243
+280
+9% +$208K 0.96% 19
2025
Q2
$2.31M Sell
2,963
-8
-0.3% -$6.22K 0.95% 18
2025
Q1
$2.45M Buy
2,971
+185
+7% +$154K 1.1% 15
2024
Q4
$2.15M Buy
2,786
+756
+37% +$626K 0.97% 18
2024
Q3
$1.8M Hold
2,030
0.86% 22
2024
Q2
$1.84M Sell
2,030
-100
-5% -$80K 0.96% 20
2024
Q1
$1.66M Hold
2,130
0.93% 21
2023
Q4
$1.24M Buy
2,130
+3
+0.1% +$1.75K 0.75% 32
2023
Q3
$1.14M Sell
2,127
-89
-4% -$45.9K 0.81% 29
2023
Q2
$1.04M Sell
2,216
-36
-2% -$15.1K 0.72% 38
2023
Q1
$773K Hold
2,252
0.58% 52
2022
Q4
$824K Hold
2,252
0.54% 54
2022
Q3
$728K Hold
2,252
0.55% 57
2022
Q2
$730K Buy
2,252
+86
+4% +$25.8K 0.51% 66
2022
Q1
$620K Buy
2,166
+1
+0% +$257 0.39% 86
2021
Q4
$598K Buy
+2,165
New +$549K 0.53% 59

Other funds holding LLY

NCM Capital Management's LLY Position: Q2 2026 in Review

NCM Capital Management reduced its Eli Lilly (LLY) stake by 0.51% in Q2 2026, selling an estimated $15.3K and leaving 2,914 shares worth $3.49M. The position accounts for 1.08% of the portfolio, ranked #17.

NCM Capital Management first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • NCM Capital Management held 2,914 shares of Eli Lilly worth $3.49M as of Q2 2026.
  • NCM Capital Management sold 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 1.08% of NCM Capital Management's portfolio in Q2 2026, its #17 holding.
  • NCM Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on NCM Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.